Fenbendazole and Cancer https://validator.w3.org/feed/docs/rss2.html Talking to Your Doctor About Off-Label Treatments Effects of fenbendazole and vitamin E succinate on the growth and survival of prostate cancer cells Home Document Library Document Search About Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials Recommended Reading Deworming Medicine Treat Breast Cancer? Mebendazole effectively overcomes imatinib resistance by dualtargeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways Contact Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells Oral Fenbendazole for Cancer Therapy in Humans and Animals Video Library Drug Repurposing Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update Drug repurposing and human parasitic protozoan diseases April 2025: This website is currently under development FAQ Resources How Fenbendazole Could Reshape Cancer Treatment Paradigms Fenbendazole Research: Bridging Veterinary Medicine and Oncology What Cancer Patients Should Know About Fenbendazole Innovative Applications of Fenbendazole in Health Care Fenbendazole’s Journey from Veterinary Use to Oncology Labs Toxicology in Vitro Debunking Myths Around Fenbendazole and Cancer Can Fenbendazole Revolutionize Cancer Therapy Approaches? The Science Behind Fenbendazole’s Role in Cancer Treatment Blog Team Sample Page Fenbendazole Cancer Success Stories: 119 Case Reports Compilation